You refuse to
compromise.

We couldn't
agree more.

You refuse to compromise.

We couldn't agree more.

With so much at stake, there is no room for compromise. Edwards SAPIEN 3 TAVI helps you:

Deliver outcomes you demand

1%

death or disabling stroke at 1 year1

Perfect the pathway through efficient procedures

96%

of patients discharged to the comfort of their home1

Control for the future to continue to meet the emerging needs of new patient populations

100%

successful post-TAVI coronary access2

For more info

Download Brochure

Find out more about the Higher Standard

Outcomes You Demand

You bring outcomes to
new heights. We are right
there with you.

Explore ›

Perfecting The Pathway

You seek perfection.
So do we.

Explore ›

Controlling For The Future

You're always thinking
ahead. We can get
behind that.

Explore ›

The valve designed to meet your Higher Standard.

Scroll / swipe side to side to review timeline

*On the primary endpoint of death, stroke, and rehospitalization at 1 year.

Clinical Study

25,000+

patients studied in Edwards clinical trials

Real world experience

450,000+

patients treated worldwide with Edwards TAVI valves

Data on file at Edwards Lifesciences.

Stay informed

References:  

1. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019.
2. Tarantini G, Fovino LN, Le Prince P, et al. Coronary access and percutaneous coronary intervention up to 3 years after transcatheter aortic valve implantation with a balloon-expandable valve. Circ Cardiovasc Interv. 2020;13(7).
3. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med. 2010.
4. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016.
5. Nazif T, Daniels D, McCabe J, Chehab B, et al. Real-world experience with the SAPIEN 3 Ultra TAVI: A propensity matched analysis from the United States. Presented virtually at TVT Connect 2020.